← Back to Search

PeptiStrong for Muscle Strength Enhancement

N/A
Recruiting
Research Sponsored by Nuritas Ltd
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Males & females between 19 and 40 years of age
Hormonal contraceptives including oral contraception, hormone birth control patch, vaginal contraceptive ring, injectable contraceptives, or hormone implant.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 56 days supplementation

Summary

This trial tests if the PeptiStrong supplement can improve muscle strength and endurance in healthy young men and women when combined with regular exercise.

Who is the study for?
This trial is for men and women aged 19-40 with a BMI of 18.5 to 29.9, who are willing to follow an exercise program three times a week without engaging in other vigorous activities two days before testing. Participants should maintain their current lifestyle, including diet and sleep patterns, avoid NSAIDs and alcohol before visits, and use contraception if necessary.
What is being tested?
The study tests PeptiStrong's effectiveness on muscle strength when combined with regular exercise compared to a placebo (an inactive substance). It's randomized (participants are assigned by chance) and double-blind (neither researchers nor participants know who gets what), ensuring unbiased results.
What are the potential side effects?
Potential side effects aren't specified here but generally could include digestive discomfort or allergic reactions from the supplement, as well as typical exercise-related issues like muscle soreness or strain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 19 and 40 years old.
Select...
I am using a form of hormonal birth control.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~56 days supplementation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 56 days supplementation for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
randomised, double-blind, placebo controlled study to evaluate the effect of PeptiStrong in conjunction with an exercise program on muscle strength in young males and females.
Secondary study objectives
To assess the effects of PeptStrong in conjunction with exercise
Other study objectives
effect of PeptiStrong in conjunction with exercise on future exploratory endpoints including blood biomarkers of muscle homeostasis pre and post exercise

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: PeptiStrong - fava bean hydrolysate preparationExperimental Treatment1 Intervention
PeptiStrong 2.4g/day will be supplemented as 5 capsules (480mg each) taken with approx. 150mL water at breakfast once per day for 56 days
Group II: Silicated micro-crystalline cellulose (SMCC)Placebo Group1 Intervention
The placebo 2.4g/day will be supplemented as 5 capsules taken with approx. 150mL water at breakfast once per day for 56 days

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for muscle injuries include physical therapy, anti-inflammatory medications, and nutritional supplementation. Physical therapy helps by promoting blood flow and muscle repair through targeted exercises. Anti-inflammatory medications reduce swelling and pain, facilitating quicker recovery. Nutritional supplements, such as creatine and quercetin, enhance muscle repair and strength by providing essential nutrients and reducing oxidative stress. PeptiStrong, a supplement studied for its effects on muscle strength and endurance, likely works by supplying peptides that support muscle protein synthesis and recovery. These mechanisms are crucial for muscle injury patients as they help accelerate healing, reduce pain, and restore muscle function, enabling a quicker return to normal activities.
ICU-acquired weakness.Quercetin Supplementation Improves Neuromuscular Function Recovery from Muscle Damage.Oral creatine supplementation augments the repeated bout effect.

Find a Location

Who is running the clinical trial?

Nuritas LtdLead Sponsor
5 Previous Clinical Trials
270 Total Patients Enrolled
2 Trials studying Muscle Injuries
46 Patients Enrolled for Muscle Injuries
~32 spots leftby Nov 2025